How much is more life worth?
Brock
Dan W
DW
Harvard Medical School, USA.
D000911:Antibodies, Monoclonal / Q000191:economics*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000191:economics*; D000068258:Bevacizumab; D003362:Cost-Benefit Analysis; D016527:Drug Costs / Q000941:ethics*; D004345:Drug Industry / Q000941:ethics*; D006801:Humans; D010330:Patents as Topic; D019057:Quality-Adjusted Life Years; D006113:United Kingdom; D014481:United States; D026712:Value of Life / Q000191:economics*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068258:Bevacizumab